Does IV Iron Induce Plasma Oxidative Stress in Critically Ill Patients? A Comparison With Healthy Volunteers*

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Critical Care Medicine

• Publication date

  2016-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/CCM.0000000000001420PMID 26605680
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• LC-MS/MS method for hepcidin-25 measurement in human and mouse serum: clinical and research implications in iron disorders

  2015cited by this paper
• A Multicenter, Randomized Clinical Trial of IV Iron Supplementation for Anemia of Traumatic Critical Illness*

  2014cited by this paper
• Prevalence of iron deficiency on ICU discharge and its relation with fatigue: a multicenter prospective study

  2014cited by this paper
• Simulation of repetitive diagnostic blood loss and onset of iatrogenic anemia in critical care patients with a mathematical model

  2013cited by this paper
• Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials

  2013cited by this paper
• Efficacy and toxicity of intravenous iron in a mouse model of critical care anemia*

  2012cited by this paper
• Plasma Biomarkers of Oxidant Stress and Development of Organ Failure in Severe Sepsis

  2011cited by this paper
• Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose

  2011cited by this paper
• Hepcidin and anemia of the critically ill patient: bench to bedside.

  2011cited by this paper
• Assessment of the extent of oxidative stress induced by intravenous ferumoxytol, ferric carboxymaltose, iron sucrose and iron dextran in a nonclinical model

  2011cited by this paper
• Iron deficiency in critically ill patients: highlighting the role of hepcidin

  2011cited by this paper
• Comparison of the renal, cardiovascular and hepatic toxicity data of original intravenous iron compounds.

  2010cited by this paper
• Diagnostic accuracy of serum hepcidin for iron deficiency in critically ill patients with anemia

  2010cited by this paper
• Low Reticulocyte Hemoglobin Content Is Associated with a Higher Blood Transfusion Rate in Critically Ill Patients: A Cohort Study

  2010cited by this paper
• Automated assay for non-transferrin-bound iron in serum samples

  2010cited by this paper
• Randomized clinical trial on acute effects of i.v. iron sucrose during haemodialysis

  2010cited by this paper
• Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness.

  2009cited by this paper
• Time course of anemia during six months follow up following intensive care discharge and factors associated with impaired recovery of erythropoiesis*

  2009cited by this paper
• Iron, oxidative stress, and clinical outcomes

  2008cited by this paper
• Iron-induced oxidative stress in haemodialysis patients: a pilot study on the impact of diabetes

  2008cited by this paper
• Phlebotomies or erythropoietin injections allow mobilization of iron stores in a mouse model mimicking intensive care anemia

  2008cited by this paper
• Two different modalities of iron gluconate i.v. administration: effects on iron, oxidative and inflammatory status in peritoneal dialysis patients.

  2007cited by this paper
• Isoprostane measurement in plasma and urine by liquid chromatography-mass spectrometry with one-step sample preparation.

  2007cited by this paper
• Slow Intravenous Iron Administration Does Not Aggravate Oxidative Stress and Inflammatory Biomarkers during Hemodialysis: A Comparative Study between Iron Sucrose and Iron Dextran

  2007cited by this paper
• Comparison of Oxidative Stress Markers After Intravenous Administration of Iron Dextran, Sodium Ferric Gluconate, and Iron Sucrose in Patients Undergoing Hemodialysis

  2007cited by this paper
• Diagnosis and management of iron-related anemias in critical illness

  2006cited by this paper
• Biomarkers of oxidative damage in human disease.

  2006cited by this paper
• Effects of Intravenous Polymaltose Iron on Oxidant Stress and Non-Transferrin-Bound Iron in Hemodialysis Patients

  2005cited by this paper
• Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease.

  2004cited by this paper
• Anemia in the critically ill.

  2004cited by this paper
• Iron supplementation in the intensive care unit: when, how much, and by what route?

  2004cited by this paper
• Isoprostanes: markers and mediators of oxidative stress

  2004cited by this paper
• High-dose exogenous iron following cecal ligation and puncture increases mortality rate in mice and is associated with an increase in gut epithelial and splenic apoptosis*

  2004cited by this paper
• The CRIT Study: Anemia and blood transfusion in the critically ill—Current clinical practice in the United States*

  2004cited by this paper
• The Effects of Intravenous Iron Treatment on Oxidant Stress and Erythrocyte Deformability in Hemodialysis Patients

  2003cited by this paper
• Induction of protein oxidation by intravenous iron in hemodialysis patients: role of inflammation.

  2002influential reference
• Labile iron in parenteral iron formulations and its potential for generating plasma nontransferrin‐bound iron in dialysis patients

  2002cited by this paper
• Dietary hydroxy fatty acids are absorbed in humans: implications for the measurement of 'oxidative stress' in vivo.

  2002cited by this paper
• Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency.

  2002cited by this paper
• Anemia and blood transfusion in critically ill patients.

  2002cited by this paper
• Anemia of the critically ill: "acute" anemia of chronic disease.

  2000cited by this paper
• Unrecognised iron deficiency in critical illness.

  1999cited by this paper
• A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.

  1999cited by this paper
• Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients*

  1999cited by this paper
• Unrecognised iron deficiency in critical illness.

  1998cited by this paper
• Toxicity of iron and hydrogen peroxide: the Fenton reaction.

  1995cited by this paper

• Studying the Intravenous Iron Sucrose in Antioxidant Status and Oxidative Stress in Pregnant Females with Iron Deficiency Anemia

  2025cites this paper
• Iron Metabolism in the Recovery Phase of Critical Illness with a Focus on Sepsis

  2024cites this paper
• Intravenous iron for critically ill children. Comparison of three dose regimens

  2023cites this paper
• A pilot study on effect of intravenous iron sucrose on oxidative stress and antioxidant status of pregnant women with iron deficiency anemia

  2023cites this paper
• Comparison of different intravenous iron preparations in terms of total oxidant and total antioxidant status, single center data

  2023cites this paper
• Patient Blood Management in der Intensivmedizin

  2023cites this paper
• Markers of Oxidative Stress, Inflammation and Endothelial Function following High-Dose Intravenous Iron in Patients with Non-Dialysis-Dependent Chronic Kidney Disease—A Pooled Analysis

  2022cites this paper
• Intravenous iron to treat anaemia following critical care: a multicentre feasibility randomised trial.

  2021cites this paper
• Impact of treating iron deficiency, diagnosed according to hepcidin quantification, on outcomes after a prolonged ICU stay compared to standard care: a multicenter, randomized, single-blinded trial

  2020cites this paper
• Micronutrient Deficiencies in Medical and Surgical Inpatients

  2019cites this paper
• Hepcidin and Anemia in Surgical Critical Care: A Prospective Cohort Study*

  2018cites this paper
• Iron deficiency diagnosed using hepcidin on critical care discharge is an independent risk factor for death and poor quality of life at one year: an observational prospective study on 1161 patients

  2018cites this paper
• Exacerbation of oxidative stress during sickle vaso‐occlusive crisis is associated with decreased anti‐band 3 autoantibodies rate and increased red blood cell‐derived microparticle level: a prospective study

  2017cites this paper
• Isoprostanes, neuroprostanes and phytoprostanes: An overview of 25years of research in chemistry and biology.

  2017cites this paper
• Patient Blood Management in der Intensivmedizin

  2017cites this paper
• Iron Use in Critically Ill Patients: No More Stress?

  2016influential citation